
A $51 million debut would make Scream 7 the strongest horror opening of 2026, reinforcing Paramount’s reliance on franchise tentpoles to drive theatrical revenue in a streaming‑heavy era.
The Scream series has long been a bellwether for horror’s box‑office viability, and its seventh chapter arrives as Paramount’s first major theatrical tentpole of 2026. Historically, the franchise has delivered strong opening weekends, with the 2022 reboot surpassing $70 million globally. By targeting a $51 million domestic debut, Paramount hopes to replicate that momentum while capitalizing on the franchise’s built‑in fan base. In an industry where streaming releases dominate, a high‑profile horror sequel offers a rare opportunity to fill cinema seats and generate ancillary revenue.
The Thursday preview generated an unprecedented $7.8 million in select markets, signaling robust fan enthusiasm ahead of the weekend. Analysts note that mixed critical reviews typically have limited sway over opening‑weekend performance, especially for genre franchises with loyal followings. Early‑ticket sales and social‑media buzz suggest that word‑of‑mouth will drive attendance more than critic scores. Moreover, the strong preview figures provide a buffer against potential drop‑offs, allowing Paramount to secure a solid cash flow before the film’s reception fully crystallizes.
Paramount’s reliance on Scream 7 underscores a broader strategic shift toward event‑driven releases that can compete with streaming giants. With Sony’s GOAT projected at $11.5 million and Warner Bros.’ Wuthering Heights at $6.7 million, the horror sequel is set to dominate the weekend box office, reaffirming the genre’s resilience. The modest earnings expected from six smaller titles highlight the widening gap between franchise powerhouses and independent releases. Success for Scream 7 could encourage studios to double down on sequels and legacy IPs as anchors for the theatrical calendar.
Comments
Want to join the conversation?
Loading comments...